Nanosphere Doubles Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere today reported that its first-quarter revenues doubled year over year driven by new customer placements of its Verigene molecular diagnostics system and respiratory virus cartridges.

The Northbrook, Ill.-based firm reported total revenues of $1.3 million for the three months ended March 31, compared to $640,000 for the first quarter of 2011. It matched analysts' consensus estimate for revenues of $1.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.